FLR vs GXO

Fluor Corporation exhibits severe operational distress, highlighted by a critical Piotroski F-Score of 0/9, indicating a total lack of improvement in financial health across all measured dimensions. Despite a stable balance sheet with low debt and healthy liquidity ratios, the company is suffering from negative profit and gross margins and a catastrophic recent earnings miss (Actual $-9.87 vs Est $0.36). The combination of declining revenue, massive EPS contraction, and bearish insider selling outweighs the optimistic analyst target prices.

GXO presents a stark contrast between deterministic value metrics and forward-looking analyst sentiment. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $57.15 trades at a massive premium to the Graham Number ($12.81) and Intrinsic Value ($1.96). However, the dramatic collapse from a trailing P/E of 204.11 to a forward P/E of 16.49 suggests a significant expected earnings recovery. While the company has a stellar 20-quarter track record of beating estimates, liquidity concerns (Current Ratio 0.85) and negative YoY earnings growth temper the bullish analyst consensus.